Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting
GlobeNewswire
· Oral presentation to discuss CRISPR-associated gene editing inactivating herpes virus
· Two poster presentations highlight..